NASDAQ$CENTA

Central Garden & Pet Company · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

Sales and profit grew, driven by recent acquisitions, despite COVID-19 headwinds.

Central Garden & Pet reported a solid second quarter with sales increasing by 4.4% to $703.2 million and diluted EPS increasing to $0.78. The growth was driven by recent acquisitions, despite challenges posed by COVID-19. Full year 2020 guidance was suspended due to the pandemic.

  • Total net sales increased 4.4% to $703.2 million compared to the second quarter a year ago, driven in large part by recent acquisitions.
  • The diluted earnings per share for the quarter was $0.78 compared to $0.73 in the prior year quarter.
  • Second quarter net sales for the Pet segment rose 6.7% to $360.8 million compared to the same period a year ago, aided by the Company's C&S acquisition.
  • Second quarter net sales for the Garden segment rose 2.1% to $342.4 million, driven by the Arden acquisition.

Headline financials

Total Revenue

$703M

Previous: $674M+4.4%
EPS (adj)

$0.62

Previous: $0.58+6.9%
Gross Margin

29.5%

Previous: 30.6%-3.6%
Operating Margin

9.4%

Previous: 9.2%+2.2%
Capital Expenditures

-$19.5M

Previous: -$14.3M-36.3%
Free Cash Flow

$23.2M

Previous: $28.1M-17.3%
Net Income

$42.7M

Previous: $42.4M+0.7%
Operating Income

$66.1M

Previous: $62.2M+6.4%
Gross Profit

$207M

Previous: $206M+0.5%
Cash & Equivalents

$332M

Previous: $330M+0.6%
Total Assets

$2.17B

Previous: $2.05B+5.9%
Stock-Based Comp

$4.27M

Previous: $3.08M+38.9%

Revenue & EPS history

Central Garden & Pet · Revenue · Quarterly

$703M

Q2 2020+4.4%vs Q2 2019
Beat estimate in 14 of 15 quarters(93%)
ActualEstimate

Revenue by segment

Central Garden & Pet · $703M total across 2 segments · Q2 2020

  • Pet Segment
    $361M+6.7%
  • Garden Segment
    $342M+2.1%

Forward guidance

Given the unprecedented uncertainty of the global COVID-19 crisis, including the lack of clarity into the future and the rapid pace of change, the Company is suspending providing guidance for fiscal 2020 until the COVID-19 situation in the US stabilizes.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

-0.4%

Avg return

Earnings day

+1.7%

Avg return

5 days after

+0.4%

Avg return

30 days after

53%

34 / 64 earnings

Positive

+18.5%

Q1 2016

Best reaction

-22.9%

Q3 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026+3.2%+2.2%+4.9%
Q1 2026+0.0%-1.4%-0.9%
Q4 2025+8.2%+8.2%+3.3%
Q2 2025+0.3%+6.3%+4.4%
Q1 2025-0.9%+0.8%+0.1%
Q4 2024-0.2%+2.9%-1.4%
Q3 2024+5.0%+0.5%+0.7%
Q2 2024+11.9%+11.8%+0.3%
Q1 2024+5.6%+14.6%+6.9%
Q4 2023-10.8%-10.2%+6.6%
Q3 2023+15.6%+12.8%+8.0%
Q2 2023+6.3%+4.0%+2.0%
Q1 2023+4.0%+7.4%+0.0%
Q4 2022-8.8%-9.0%-13.4%
Q3 2022+0.7%+3.2%-11.3%
Q2 2022+0.7%+3.7%+2.7%
Q1 2022+0.3%-6.3%-1.1%
Q4 2021-3.6%-5.4%-2.8%
Q3 2021-3.0%-1.9%-8.0%
Q2 2021+5.8%+5.5%-1.0%
Q1 2021+5.2%+6.3%+11.8%
Q4 2020+1.7%+0.2%-6.1%
Q3 2020+7.1%+6.3%-0.1%
Q2 2020+2.3%+8.4%+10.7%
Q1 2020-1.8%-3.8%-10.8%
Q4 2019-18.4%-16.5%+0.1%
Q3 2019-22.9%-24.1%-12.7%
Q2 2019+4.4%+5.4%+2.6%
Q1 2019-21.0%-22.2%-24.5%
Q4 2018+2.6%+10.0%+4.8%
Q3 2018-0.4%+0.7%-9.4%
Q2 2018+5.4%+9.8%+13.5%
Q1 2018+8.6%+5.4%+7.7%
Q4 2017+3.5%+5.3%+4.1%
Q3 2017+11.7%+11.0%+12.4%
Q2 2017+3.3%+0.2%-6.7%
Q1 2017-4.3%-7.1%+0.6%
Q4 2016+9.0%+12.3%+12.9%
Q3 2016+7.1%+7.7%+6.0%
Q2 2016-2.8%
Q1 2016+18.5%
Q4 2015+14.9%
Q3 2015+3.1%
Q2 2015-4.3%
Q1 2015+3.5%
Q4 2014+4.1%
Q3 2014-0.4%
Q2 2014-7.4%
Q1 2014+7.5%
Q4 2013-11.5%
Q3 2013-13.5%
Q2 2013-12.0%
Q1 2013-2.8%
Q4 2012-13.1%
Q3 2011-4.2%
Q4 2011-4.2%
Q3 2012-6.1%
Q2 2012-7.4%
Q1 2011+1.4%
Q1 2012+4.7%
Q2 2011-3.6%
Q4 2009-3.6%
Q3 2010-14.7%
Q4 2010-14.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro